Multi-gene mutations detection kit

The Multi-Gene Mutations Detection Kit is a real-time PCR assay that allows for the detection of a wide range of mutations across multiple cancer-related genes in a single test, making personalised treatment more accessible and efficient. It supports the identification of clinically relevant biomarkers for patients with non-small cell lung cancer (NSCLC) who may be eligible for approved targeted therapies. The kit is designed for simplicity and cost-effectiveness, enabling healthcare providers to conduct multi-gene testing with fewer resources.

Benefits of the Multi-Gene Mutations Detection Kit

• Comprehensive mutation screening – detects 118 variants across 9 key genes (KRAS, NRAS, BRAF, PIK3CA, ROS1, RET, HER2, ALK, EGFR) in a single test.
• Guides targeted therapy selection – helps identify clinically relevant biomarkers for NSCLC patients, ensuring eligibility for approved treatments.
• Fast and cost-effective – uses real-time PCR technology for rapid results at a lower cost than next-generation sequencing.
• High sensitivity and accuracy – delivers reliable mutation detection with a well-validated, laboratory-friendly workflow.
• Designed for clinical use – IVD-certified for use by trained professionals, ensuring quality-controlled diagnostic testing in a lab environment.

Applications of the Multi-Gene Mutations Detection Kit

• Multi-gene mutation profiling in NSCLC (KRAS, NRAS, BRAF, PIK3CA, ROS1, RET, HER2, ALK, EGFR)
• Guiding targeted therapy decisions for lung cancer patients
• Oncology biomarker discovery and validation
• Precision medicine research and clinical trials
• IVD-approved diagnostic use in pathology and molecular labs

Specifications

Materials for download

AmoyDx Multi-Gene Mutations Detection Kit user manual